Investment in UK biotech is up 40% in 2019
Investment in UK biotech has climbed dramatically year-on-year in the early part of 2019, according to a BIA report.
Archives for March 27, 2019
Merck extends research agreement for NASH drug candidate
Merck exercises its option to extend research phase with NGM for an additional two-year period, moving the collaboration end date to March 2022.